세계의 헬스케어용 대체 불가능 토큰(NFT) 시장 : 사용 블록체인별, 용도 분야별, 최종 용도별, 지역별 업계 동향 및 예측(-2035년)

Non-fungible Tokens (NFT) in Healthcare Market by Blockchain Used, Application Area, End-user and Geographical Regions: Industry Trends and Global Forecasts, till 2035

US $ 4,799 ￦ 6,609,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,639,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,596,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 24,788,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

헬스케어용 대체 불가능 토큰(NFT) 시장

세계의 헬스케어용 대체 불가능 토큰(NFT) 시장 규모는 2021년에 1억 5,400만 달러로 평가되었고, 2025년에는 2억 810만 달러로 추정되며, 2035년에는 1조 1,168억 달러에 이를 것으로 예측되고, 예측 기간 중 CAGR 18.3%로 전망되고 있습니다.

헬스케어용 대체 불가능 토큰(NFT)의 기회는 다음과 같은 부문에 분산되어 있습니다.

사용되는 블록체인

• 이더리움
• 하이퍼 레저
• 다각형
• 기타

용도 분야

• 의료기록관리
• 공급망 관리
• 유전체 연구
• 건강 및 웰빙
• 임상시험 동의서
• 기타

최종 사용자

• 헬스케어 관계자
• 환자
• 제약회사
• 학술기관 및 정부기관
• 보험회사
• 기타

지역

• 북미(미국, 캐나다)
• 유럽(독일, 영국, 스페인, 기타)
• 아시아태평양(중국, 한국, 인도 등)
• 중동 및 북아프리카(사우디아라비아, UAE, 기타)
• 라틴아메리카(브라질, 아르헨티나, 기타)

헬스케어용 대체 불가능 토큰(NFT) 시장 : 성장 및 동향

NFT 시장은 급속히 발전하고 있는 분야이며, 분산형 블록체인 기술을 통합함으로써 여러 업계에 변화를 가져오고 있습니다. 블록체인 기술을 도입함으로써 다양한 업계가 중앙 집중식 시스템에서 분산형 네트워크로의 이행을 촉진하고 거래 속도 향상, 비용 절감, 데이터 무결성 향상 등 몇 가지 이점이 발생하고 있습니다. NFT는 블록체인 상에 저장되고 토큰화되기 때문에 (앞에서 언급한) 몇 가지 이점이 있다는 점은 주목할 만합니다. 이러한 이점이 최근 NFT 도입이 확대되고 있는 한 요인이 되고 있습니다. 실제로 2021년 NFT 시장은 NFT 거래로 400억 달러 이상의 수익을 창출했습니다. 이것의 주된 요인은, NFT의 역사에 큰 돌파를 가져온 아트 워크 업계에 있어서 중요한 사건(디지털 아티스트의 Beeple이 6,900만 달러 상당의 작품을 매각)에 있습니다.

NFT는 블록체인 기술에 의해 토큰화된 아트 작품, 의료 데이터, 비디오 클립 등의 자산을 디지털로 표현한 것입니다. 토큰화된 정보에는 제3자가 접근할 수 없기 때문에 NFT는 가분성이 없고 불변하며 높은 보안과 프라이버시를 제공한다는 특징이 있습니다. 위의 특징 때문에 NFT는 아트, 공급망, 패션, 게임, 헬스케어, 부동산 등 다양한 분야에서 이용되고 있습니다. 게다가 NFT는 암호화폐와 블록체인 시장에 종사하는 투자자와 이해관계자들로부터 큰 관심을 받고 있어 도입 확대에 기여하고 있습니다.

헬스케어는 공급망 추적, 건강 기록 관리, 유전체 연구, 헌혈, 임상시험 동의, 헬스케어 및 웰니스 프로그램과 같은 여러 용도 분야에서 NFT를 사용합니다. 특히 의료기록용 NFT는 헬스케어 업계에서 가장 일반적으로 사용되고 있어 환자가 자신의 건강 관련 데이터를 관리하고 제약사 및 연구기관과 거래하는 것을 가능하게 하고 있습니다. 더불어 헬스케어 분야에서 NFT의 가능성을 충분히 이끌어내기 위해 NFT 솔루션을 제공하는 다양한 기업들이 데이터의 안전하고 투명한 저장과 공유를 가능하게 하는 혁신적인 플랫폼 개발도 진행하고 있습니다.

블록체인과 관련 첨단 기술에 대한 인식이 높아지고 도입이 진행되고 있기 때문에 헬스케어 업계에서 NFT 솔루션 수요는 안정된 페이스로 증가하고 있습니다. 게다가 저명인사에 의한 디지털 자산의 권장이나, 헬스케어 데이터의 취급이 급선무가 되고 있는 것으로부터, 헬스케어용 NFT 시장은 향후 수년간에 안정된 성장이 전망됩니다.

헬스케어용 대체 불가능 토큰(NFT) 시장 : 주요 인사이트

이 보고서는 헬스케어용 NFT 시장의 현재 상태를 조사하고 잠재적 성장 기회를 확인합니다. 주요 조사 결과는 다음과 같습니다. :

• 다양한 헬스케어에서 보안과 신뢰성의 요구에 뒷받침되어, 30개가 넘는 NFT 솔루션이 출시 및 개발되고 있습니다.

• 현재 65% 이상의 NFT 플랫폼이 시장에서 이용 가능하며, 그 중 30%는 데이터 공유, 스마트 계약, 분산화, 토큰화, 불변성, 보안 등 주요 기능을 모두 갖추고 있습니다.

• 이 분야에서 체결된 거래의 약 45%는 의료 데이터 관리와 접근성을 향상시키는 NFT 솔루션의 강화에 초점을 맞춘 것으로, 대륙간 거래의 대부분은 북미를 거점으로 하는 진출 기업에 의해 체결되었습니다.
• 지난 몇 년 동안 헬스케어용 NFT 솔루션 제공 업체는 다양한 자금 조달 라운드를 통해 9,000만 달러 이상을 조달했습니다.
• 암호화폐의 보급과 환자의 수익화 기회 증가는 헬스케어용 대체 불가능 토큰(NFT) 시장을 견인해, 당분간은 안정된 성장이 전망됩니다.

• NFT가 제공하는 비교할 수 없는 데이터 보안과 함께 비중앙 집권화 등의 원칙에 대한 의식이 높아지고 있기 때문에 이 시장은 2035년까지 연률 18.3%(CAGR)로 성장할 것으로 예측되고 있습니다.

헬스케어용 대체 불가능 토큰(NFT) 시장 : 주요 부문

사용 블록체인별로 세계의 헬스케어용 대체 불가능 토큰(NFT) 시장은 이더리움, 하이퍼레저, 다각형 및 기타 블록체인으로 세분화됩니다. 현재 헬스케어용 NFT 시장의 대부분의 점유율을 차지하고 있는 것은 이더리움 블록체인 네트워크를 이용한 NFT 솔루션입니다. 이는 이더리움 블록체인이 보안과 프라이버시를 강화하고(스마트 컨트랙트를 구현한 최초의 블록체인이기 때문에) 제3자 검증을 필요로 하지 않는다는 사실에 기인합니다. 다른 블록체인을 활용한 NFT 솔루션은 향후 몇 년간 큰 속도로 성장할 가능성이 높다는 점은 특기할 만합니다.

용도 분야별로 세계의 헬스케어용 NFT 시장은 의료 기록 관리, 공급망 관리, 유전체 연구, 건강 및 웰니스, 임상시험 동의 및 기타 용도 분야로 분산되어 있습니다. NFT는 전자 진료기록카드 추적을 효율적으로 수행하고 정확한 진단과 치료를 지원하기 때문에 현재로서는 진료기록카드 관리 분야가 시장 전체를 지배할 가능성이 높습니다. 특히 이 동향은 예측 기간 중에도 바뀔 것 같지 않습니다.

세계의 NFT 시장은 최종 사용자별로는 의료 종사자, 환자, 제약회사, 학술기관 및 정부기관, 보험회사, 기타 최종 사용자로 구분됩니다. 주목할 점은 현재 시장은 의료 종사자들이 이용하는 NFT 솔루션이 지배적일 것이라는 점입니다. 그러나 향후 수년간 환자의 요구에 부응하는 NFT 솔루션이 큰 폭의 성장을 이룰 것으로 예상됩니다.

지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, 중동, 북아프리카, 라틴아메리카로 구분됩니다. 현재 시나리오로는 북미가 헬스케어용 NFT 시장을 독점할 가능성이 높습니다. 그러나 연구개발 활동의 활성화, 인지도 향상, NFT 솔루션의 채택 증가로 아시아태평양의 헬스케어용 NFT 시장은 예측 기간 동안 더 높은 CAGR로 성장할 것으로 예상됩니다.

이 보고서에서 답변을 얻을 수 있는 주요 질문

• 현재, 이 시장에 참가하고 있는 기업은 몇사인가
• 이 시장의 주요 기업
• 이 시장의 진화에 영향을 줄 것 같은 요인
• 현재 및 미래 시장 규모
• 이 시장의 CAGR
• 현재 및 미래 시장 기회는 주요 시장 부문에 어떻게 분배될 것인가
• 업계 이해관계자가 일반적으로 채용하고 있는 파트너십 모델의 유형
• 이 시장에서 진행 중인 투자 동향

이 보고서를 구입하는 이유

• 이 보고서는 종합적인 시장 분석을 제공하며 시장 전체와 특정 하위 부문에 대한 자세한 수익 예측을 제공합니다. 이 정보는 이미 시장을 선도하고 있는 기업에 있어서도, 신규 참가 기업에 있어서도 귀중한 것입니다.
• 이해관계자는 시장 내 경쟁 역학을 보다 깊이 이해하기 위해 보고서를 활용할 수 있습니다. 경쟁 상황을 분석함으로써 기업은 시장에서의 포지셔닝을 최적화하고 효과적인 시장 진입 전략을 개발하기 위해 정보에 입각한 의사결정을 할 수 있습니다.
• 이 보고서는 주요 촉진요인 및 시장 성장 억제요인과 과제 등 시장의 종합적인 개요를 이해관계자에게 제공합니다. 이 정보는 이해관계자가 시장 동향을 항상 파악하고 성장 전망을 활용하기 위한 데이터 주도의 의사 결정을 하기 위한 힘이 됩니다.

기타 혜택

• PPT 인사이트 팩
• 보고서의 모든 분석 모듈의 무료 엑셀 데이터 팩
• 10% 무료 컨텐츠 커스터마이즈
• 조사팀에 의한 상세 보고서의 워크스루 세션
• 보고서가 6-12개월 이상 전인 경우, 무료 갱신 보고서

이 보고서는 세계의 헬스케어용 대체 불가능 토큰(NFT) 시장을 조사했으며, 시장 개요와 함께 사용 블록체인별, 용도 분야별, 최종 용도별, 지역별 동향, 시장 진출 기업 프로파일 등의 정보를 제공합니다.

목차

섹션 I : 보고서 개요

제1장 배경

제2장 조사 방법

제3장 시장 역학

제4장 거시경제지표

섹션 II : 질적 인사이트

제5장 주요 요약

제6장 서문

• 대체 불가능 토큰(NFT) 개요
• 블록체인 프로세스
• NFT의 주요 특징
• NFT 이용 사례
• 헬스케어용 NFT의 용도
• 헬스케어용 NFT의 과제
• 장래의 전망

섹션 III : 시장 개요

제7장 경쟁 구도

• 조사 방법 및 주요 파라미터
• 헬스케어용 대체 불가능 토큰(NFT) 솔루션 : 시장 상황
• 헬스케어용 대체 불가능 토큰(NFT) 솔루션 공급자 : 시장 상황

제8장 기업 경쟁력 분석

• 조사 방법 및 주요 파라미터
• 채점 기준
• 피어 그룹
• 의료 솔루션 제공업체의 NFT : 기업 경쟁력 분석
• 의료 솔루션 제공업체의 NFT : 벤치마크 분석

섹션 IV : 기업 프로파일

제9장 기업 프로파일

섹션 V : 시장 동향

제10장 파트너십 및 협업

• 파트너십 모델
• 헬스케어용 NFT : 파트너십 및 협업

제11장 자금조달 및 투자

• 자금 조달 모델
• 헬스케어용 NFT : 자금 조달 및 투자
• 요약 및 중요한 포인트

제12장 헬스케어용 대체 불가능 토큰(NFT) : 이용 사례

• NFT 이용 사례 개요
• NFT 잠재적인 사용예

섹션 VI : 시장 예측 및 기회 분석

제13장 시장 영향 분석 : 촉진요인, 억제요인, 기회, 과제

• 시장 개요
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 시장 과제
• 결론

제14장 세계의 헬스케어용 대체 불가능 토큰(NFT)

• 주요 전제 및 조사 방법
• 세계의 헬스케어용 대체 불가능 토큰(NFT) : 과거 동향(2021년-) 및 예측 추정(-2035년)
• 주요 시장 세분화

제15장 헬스케어용 대체 불가능 토큰(NFT) 시장 : 사용 블록체인별

제16장 헬스케어용 대체 불가능 토큰(NFT) 시장 : 용도 분야별

제17장 헬스케어용 대체 불가능 토큰(NFT) 시장 : 최종 사용자별

제18장 헬스케어용 대체 불가능 토큰(NFT) 시장 : 지역별

섹션 VII : 지리적 지역 시장 기회 분석

제19장 시장 기회 분석 : 북미

제20장 시장 기회 분석 : 유럽

제21장 시장 기회 분석 : 아시아태평양

제22장 시장 기회 분석 : 중동 및 북아프리카

제23장 시장 기회 분석 : 라틴아메리카

섹션 VIII : 전략 도구

제24장 Porter's Five Forces 분석

섹션 IX : 기타 독점 통찰

제25장 결론

제26장 1차 조사로부터의 인사이트

섹션 X : 부록

제27장 표 형식 데이터

제28장 기업 및 단체 일람

AJY

영문 목차

영문목차

NON-FUNGIBLE TOKENS (NFT) IN HEALTHCARE MARKET

As per Roots Analysis, the global NFT in healthcare market, valued at USD 154.0 million in 2021, is projected to reach USD 208.1 million in 2025 and USD 1,116.8 billion by 2035, representing a CAGR of 18.3% during the forecast period.

The opportunity for NFT in the healthcare market has been distributed across the following segments:

Blockchain Used

• Ethereum
• HyperLedger
• Polygon
• Other Blockchains

Application Area

• Health Records Management
• Supply Chain Management
• Genomics Research
• Health and Wellness
• Clinical Trial Consent
• Other Application Areas

End-user

• Healthcare Professionals
• Patients
• Pharmaceutical Companies
• Academic Institutions / Government Bodies
• Insurance Companies
• Other End-users

Geographical Regions

• North America (US and Canada)
• Europe (Germany, UK, Spain and Rest of the Europe)
• Asia-Pacific (China, South Korea, India and Rest of the Asia-Pacific)
• Middle East and North Africa (Saudi Arabia, UAE and Rest of the Middle East and North Africa)
• Latin America (Brazil, Argentina and Rest of the Latin America)

NFT IN HEALTHCARE MARKET: GROWTH AND TRENDS

The NFT market is a rapidly evolving sector that is transforming several industries by integrating decentralized blockchain technology. The incorporation of blockchain technology has prompted various industries to shift from centralized systems to decentralized networks, offering several advantages, such as enhanced transaction speeds, reduced costs, and improved data integrity. It is worth highlighting that NFTs are stored and tokenized on blockchain and therefore offer several advantages (mentioned above). These advantages have further contributed to the increased adoption of NFTs in recent years. In fact, in 2021, the NFT market generated more than USD 40 billion in revenues by trading NFTs; primarily attributed to an important event in the artwork industry (wherein Beeple, a digital artist, sold a piece of his artwork worth USD 69 million) that marked a significant breakthrough in the history of NFTs.

NFTs are distinct digital representations of assets, such as artwork, medical data, and video clips that have been tokenized through blockchain technology. It is worth noting that NFTs are non-divisible, immutable, and provide high security and privacy, since third parties cannot access the tokenized information. Owing to the abovementioned features, NFTs are being used across multiple disciplines, such as art, supply chain, fashion, gaming, healthcare, and real estate. Further, NFTs have gained significant interest from investors and stakeholders engaged in the cryptocurrency and blockchain market, contributing to their increased adoption.

In healthcare, NFTs are being used for several applications, including tracking supply chain, managing health records, genomics research, blood donation, clinical trial consent, healthcare and wellness programs. Notably, the NFTs for medical records are most commonly used in the healthcare industry, which allows patients to control their health-related data and trade it with pharmaceutical firms and research institutions. Moreover, to fully realize the potential of NFTs in the healthcare sector, various companies providing NFT solutions are also developing innovative platforms that enable secure and transparent storage and sharing of data.

Given the rising awareness and increased adoption of blockchain and related advanced technologies, the demand for NFT solutions in the healthcare industry is increasing at a steady pace. Moreover, the celebrity endorsements of digital assets and the urgent need to handle healthcare data, the NFT in healthcare market is expected to witness steady growth in the forthcoming years.

NFT IN HEALTHCARE MARKET: KEY INSIGHTS

The report delves into the current state of the NFT in healthcare market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• Driven by the need for security and reliability across various healthcare applications, over 30 NFT solutions have been launched / under development; notably, the market landscape primarily features the presence of new entrants.

• Presently, more than 65% of the NFT platforms are available in the market; of these, 30% of the platforms have all the key features, namely data sharing, smart contracts, decentralization, tokenization, immutability and security.

• Around 45% of the deals inked in this domain were focused on enhancing NFT solutions to improve health data management and accessibility; the majority of the intercontinental deals were signed by players based in North America.
• Over the past few years, more than USD 90 million has been raised across various funding rounds by NFT solution providers in healthcare; of which, 80% of the total amount was raised by players based in Europe.
• The rise in adoption of cryptocurrencies coupled with monetization opportunities for patients drives the non-fungible tokens in healthcare market, positioning it for steady growth in the foreseeable future.

• Given the rising awareness regarding principles such as decentralization coupled with unmatched data security offered by NFTs, the market is anticipated to grow at an annualized rate (CAGR) of 18.3% till 2035.

NFT IN HEALTHCARE MARKET: KEY SEGMENTS

NFT Solutions Utilizing Ethereum Blockchain Network is Likely to Dominate the NFT in Healthcare Market During the Forecast Period

Based on the blockchain used, the global NFT in healthcare market is segmented into Ethereum, HyperLedger, Polygon and other blockchains. Currently, the majority share of the NFT in healthcare market is captured by NFT solutions utilizing Ethereum blockchain network. This can be attributed to the fact that Ethereum blockchain offers enhanced security and privacy (as this was the first blockchain to implement smart contracts) and does not require third-party verification. It is worth mentioning that the NFT solutions utilizing other blockchains are likely to grow at a significant pace in the coming years.

Health Records Management Segment is Likely to Hold the Largest Share of the NFT in Healthcare Market During the Forecast Period

Based on the application area, the global NFT in healthcare market is distributed across health records management, supply chain management, genomics research, health and wellness, clinical trial consent and other application areas. Currently, the health records management segment is likely to dominate the overall market, as NFTs enable the tracking of electronic health records effectively, which supports accurate diagnosis and treatment. Notably, this trend is unlikely to change during the forecast period.

Currently, NFT Solutions Catering to Healthcare Professionals Hold the Largest Share of the NFT in Healthcare Market

Based on the end-user, the global NFT in healthcare market is segmented into healthcare professionals, patients, pharmaceutical companies, academic institutions / government bodies, insurance companies and other end-users. It is worth noting that the current market is likely to be dominated by NFT solutions being utilized by healthcare professionals. However, in the coming years, the NFT solutions catering to patient needs are expected to witness substantial growth.

North America Accounts for the Largest Share of the Market

Based on geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. In the current scenario, North America is likely to dominate the NFT in healthcare market. However, owing to the increasing research and development activity, rising awareness and increased adoption of NFT solutions, the NFT in healthcare market in Asia-Pacific is expected to grow at a higher CAGR during the forecast period.

Example Players in the NFT in Healthcare Market

• Aimedis
• BurstIQ
• ChainCode Consulting
• DeHealth
• Epillo Health
• GenoBank.io
• Genomes.io
• IVIRSE
• Molecule
• Rejuve.AI
• TuumIO
• Universal Health Token

NFT IN HEALTHCARE MARKET: RESEARCH COVERAGE

The report on NFT in healthcare market features insights into various sections, including:

• Market Sizing and Opportunity Analysis: An in-depth analysis of NFT in healthcare market, focusing on key market segments, including [A] blockchain used, [B] application area, [C] end-user, and [D] geographical regions.
• Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
• NFT Solutions Market Landscape: An insightful analysis of various NFT solutions based on several relevant parameters, such as [A] stage of development, [B] key features, [C] application area, and [D] end-user. Additionally, this section also features analyses of the companies engaged in this domain, based on [A] company size, [B] location of headquarters, and [C] year of establishment.
• Company Competitiveness Analysis: An insightful competitiveness analysis of NFT solution providers based on various relevant parameters, such as [A] supplier strength, [B] portfolio strength, and [C] portfolio diversity.
• Company Profiles: Elaborate profiles of leading players developing NFT solutions across various geographies, including North America, Europe, Asia-Pacific and rest of the world, providing details on [A] company overview, [B] NFT solution overview, [C] recent developments and [D] an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders engaged in NFT in healthcare industry, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] application area, [E] most active players and [F] geographical distribution of partnership activity.
• Funding and Investment Analysis: An in-depth analysis of funding and investments made in the NFT in healthcare domain, based on relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD million), [D] geography, and [E] most active players.
• Case Study: A detailed assessment of the existing and potential use cases of non-fungible tokens across several healthcare applications, highlighting their capacity to revolutionize health data management and enhancing patient care.
• Porter's Five Forces Analysis: An analysis of five competitive forces prevailing in the NFT in healthcare industry, including threats of new entrants, bargaining power of buyers, bargaining power of NFT in healthcare solution providers, threats of substitute products and rivalry among existing competitors.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?
• What types of partnership models are commonly adopted by industry stakeholders?
• What is the ongoing investment trend in this market?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. BACKGROUND

• 1.1. Context
• 1.2. Project Objectives

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
  • 2.2.1. Market Landscape and Market Trends
  • 2.2.2. Market Forecast and Opportunity Analysis
  • 2.2.3. Comparative Analysis
• 2.3. Database Building
  • 2.3.1. Data Collection
  • 2.3.2. Data Validation
  • 2.3.3. Data Analysis
• 2.4. Project Methodology
  • 2.4.1. Secondary Research
    • 2.4.1.1. Annual Reports
    • 2.4.1.2. Academic Research Papers
    • 2.4.1.3. Company Websites
    • 2.4.1.4. Investor Presentations
    • 2.4.1.5. Regulatory Filings
    • 2.4.1.6. White Papers
    • 2.4.1.7. Industry Publications
    • 2.4.1.8. Conferences and Seminars
    • 2.4.1.9. Government Portals
    • 2.4.1.10. Media and Press Releases
    • 2.4.1.11. Newsletters
    • 2.4.1.12. Industry Databases
    • 2.4.1.13. Roots Proprietary Databases
    • 2.4.1.14. Paid Databases and Sources
    • 2.4.1.15. Social Media Portals
    • 2.4.1.16. Other Secondary Sources
  • 2.4.2. Primary Research
    • 2.4.2.1. Types of Primary Research
      • 2.4.2.1.1. Qualitative Research
      • 2.4.2.1.2. Quantitative Research
      • 2.4.2.1.3. Hybrid Approach
    • 2.4.2.2. Advantages of Primary Research
    • 2.4.2.3. Techniques for Primary Research
      • 2.4.2.3.1. Interviews
      • 2.4.2.3.2. Surveys
      • 2.4.2.3.3. Focus Groups
      • 2.4.2.3.4. Observational Research
      • 2.4.2.3.5. Social Media Interactions
    • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
      • 2.4.2.4.1. Company Executives (CXOs)
      • 2.4.2.4.2. Board of Directors
      • 2.4.2.4.3. Company Presidents and Vice Presidents
      • 2.4.2.4.4. Research and Development Heads
      • 2.4.2.4.5. Technical Experts
      • 2.4.2.4.6. Subject Matter Experts
      • 2.4.2.4.7. Scientists
      • 2.4.2.4.8. Doctors and Other Healthcare Providers
    • 2.4.2.5. Ethics and Integrity
      • 2.4.2.5.1. Research Ethics
      • 2.4.2.5.2. Data Integrity
  • 2.4.3. Analytical Tools and Databases
• 2.5. Robust Quality Control

3. MARKET DYNAMICS

• 3.1. Chapter Overview
• 3.2. Forecast Methodology
  • 3.2.1. Top-down Approach
  • 3.2.2. Bottom-up Approach
  • 3.2.3. Hybrid Approach
• 3.3. Market Assessment Framework
  • 3.3.1. Total Addressable Market (TAM)
  • 3.3.2. Serviceable Addressable Market (SAM)
  • 3.3.3. Serviceable Obtainable Market (SOM)
  • 3.3.4. Currently Acquired Market (CAM)
• 3.4. Forecasting Tools and Techniques
  • 3.4.1. Qualitative Forecasting
  • 3.4.2. Correlation
  • 3.4.3. Regression
  • 3.4.4. Extrapolation
  • 3.4.5. Convergence
  • 3.4.6. Sensitivity Analysis
  • 3.4.7. Scenario Planning
  • 3.4.8. Data Visualization
  • 3.4.9. Time Series Analysis
  • 3.4.10. Forecast Error Analysis
• 3.5. Key Considerations
  • 3.5.1. Demographics
  • 3.5.2. Government Regulations
  • 3.5.3. Reimbursement Scenarios
  • 3.5.4. Market Access
  • 3.5.5. Supply Chain
  • 3.5.6. Industry Consolidation
  • 3.5.7. Pandemic / Unforeseen Disruptions Impact
• 3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

• 4.1. Chapter Overview
• 4.2. Market Dynamics
  • 4.2.1. Time Period
    • 4.2.1.1. Historical Trends
    • 4.2.1.2. Current and Forecasted Estimates
  • 4.2.2. Currency Coverage
    • 4.2.2.1. Major Currencies Affecting the Market
    • 4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
    • 4.2.2.3. Impact of Currency Fluctuations on the Industry
  • 4.2.3. Foreign Currency Exchange Rate
    • 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
    • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 4.2.4. Recession
    • 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
  • 4.2.5. Inflation
    • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
  • 4.2.6. Interest Rates
    • 4.2.6.1. Interest Rates and Their Impact on the Market
    • 4.2.6.2. Strategies for Managing Interest Rate Risk
  • 4.2.7. Commodity Flow Analysis
    • 4.2.7.1. Type of Commodity
    • 4.2.7.2. Origins and Destinations
    • 4.2.7.3. Values and Weights
    • 4.2.7.4. Modes of Transportation
  • 4.2.8. Global Trade Dynamics
    • 4.2.8.1. Import Scenario
    • 4.2.8.2. Export Scenario
    • 4.2.8.3. Trade Policies
    • 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
    • 4.2.8.5. Impact of Trade Barriers on the Market
  • 4.2.9. War Impact Analysis
    • 4.2.9.1. Russian-Ukraine War
    • 4.2.9.2. Israel-Hamas War
  • 4.2.10. COVID Impact / Related Factors
    • 4.2.10.1. Global Economic Impact
    • 4.2.10.2. Industry-specific Impact
    • 4.2.10.3. Government Response and Stimulus Measures
    • 4.2.10.4. Future Outlook and Adaptation Strategies
  • 4.2.11. Other Indicators
    • 4.2.11.1. Fiscal Policy
    • 4.2.11.2. Consumer Spending
    • 4.2.11.3. Gross Domestic Product
    • 4.2.11.4. Employment
    • 4.2.11.5. Taxes
    • 4.2.11.6. Stock Market Performance
    • 4.2.11.7. Cross Border Dynamics
• 4.3. Conclusion

SECTION II: QUALITATIVE INSIGHTS

5. EXECUTIVE SUMMARY

6. INTRODUCTION

• 6.1. Overview of Non-fungible Tokens (NFTs)
• 6.2. Blockchain Process
• 6.3. Key Features of NFTs
• 6.4. NFTs Use Cases
• 6.5. Applications of NFTs in Healthcare
• 6.6. Challenges Associated with NFTs in Healthcare Domain
• 6.7. Future Perspectives

SECTION III: MARKET OVERVIEW

7. COMPETITIVE LANDSCAPE

• 7.1. Methodology and Key Parameters
• 7.2. NFT Solutions in Healthcare: Overall Market Landscape
  • 7.2.1. Analysis by Stage of Development
  • 7.2.2. Analysis by Key Features of NFTs
  • 7.2.3. Analysis by Application Area
  • 7.2.4. Analysis by End-user
• 7.3. NFT Solution Providers in Healthcare: Overall Market Landscape
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Location of Headquarters

8. COMPANY COMPETITIVENESS ANALYSIS

• 8.1. Methodology and Key Parameters
• 8.2. Scoring Criteria
• 8.3. Peer Groups
  • 8.3.1. Overview of Peer Groups
• 8.4. NFT in Healthcare Solution Providers: Company Competitiveness Analysis
  • 8.4.1. NFT Solution Providers in North America: Peer Group I
    • 8.4.1.1. Leading Players in Peer Group I
  • 8.4.2. NFT Solution Providers in Europe: Peer Group II
    • 8.4.2.1. Leading Players in Peer Group II
  • 8.4.3. NFT Solution Providers in Asia-Pacific and Rest of the World: Peer Group III
    • 8.4.3.1. Leading Players in Peer Group III
• 8.5. NFT in Healthcare Solution Providers: Benchmarking Analysis
  • 8.5.1. Benchmarking of Supplier Strength Score
  • 8.5.2. Benchmarking of Portfolio Strength Score
  • 8.5.3. Benchmarking of Portfolio Diversity Score

SECTION IV: COMPANY PROFILES

9. COMPANY PROFILES

• 9.1. Overview
• 9.2. Leading Non-fungible Token Solution Providers in Healthcare
  • 9.2.1. Aimedis
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Company Mission
    • 9.2.1.3. Management Team
    • 9.2.1.4. Contact Details
    • 9.2.1.5. NFT Solution Overview
    • 9.2.1.6. Recent Initiatives
  • 9.2.2. BurstIQ
  • 9.2.3. DeHealth
  • 9.2.4. GenoBank.io
  • 9.2.5. Tuumio
• 9.3. Other Prominent Non-fungible Token Solution Providers in Healthcare
  • 9.3.1. ChainCode Consulting
    • 9.3.1.1. Company Mission
    • 9.3.1.2. Management Team
    • 9.3.1.3. NFT Solution Overview
    • 9.3.1.4. Recent Initiatives
  • 9.3.2. Epillo Health
  • 9.3.3. Genomes.io
  • 9.3.4. IVIRSE
  • 9.3.5. Molecule
  • 9.3.6. Rejuve.AI
  • 9.3.7. Universal Health Token

SECTION V: MARKET TRENDS

10. PARTNERSHIPS AND COLLABORATIONS

• 10.1. Partnership Models
• 10.2. Non-fungible Tokens in Healthcare: Partnerships and Collaborations
  • 10.2.1. Analysis by Year of Partnership
  • 10.2.2. Analysis by Type of Partnership
  • 10.2.3. Analysis by Year and Type of Partnership
  • 10.2.4. Analysis by Type of Partner
  • 10.2.5. Analysis by Application Area
  • 10.2.6. Analysis by Geographical Activity
  • 10.2.7. Most Active Players: Analysis by Number of Partnerships

11. FUNDING AND INVESTMENTS

• 11.1. Funding Models
• 11.2. Non-fungible Tokens in Healthcare: Funding and Investments
  • 11.2.1. Analysis by Year of Funding
  • 11.2.2. Analysis of Funding Instances by Type of Funding
  • 11.2.3. Analysis of Funding Instances by Year and Type of Funding
  • 11.2.4. Analysis of Amount Invested by Type of Funding
  • 11.2.5. Analysis of Funding Instances by Country
  • 11.2.6. Most Active Players: Analysis by Amount Raised
• 11.3. Summary and Key Takeaways

12. NON-FUNGIBLE TOKENS IN HEALTHCARE: USE CASES

• 12.1. Overview of NFT Use Cases
  • 12.1.1. Use Case 1: Auctioning Genomic Data
  • 12.1.2. Use Case 2: DNA Kits
  • 12.1.3. Use Case 3: Blood Donation
  • 12.1.4. Use Case 4: Stem Cell Research
  • 12.1.5. Use Case 5: Digital Health Clinics
  • 12.1.6. Use Case 6: Charitable Health NFTs
  • 12.1.7. Use Case 7: Marketing NFTs
  • 12.1.8. Use Case 8: Supply Chain Traceability
• 12.2. Potential NFT Use Cases

SECTION VI: MARKET FORECAST AND OPPORTUNITY ANALYSIS

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 13.1. Chapter Overview
• 13.2. Market Drivers
• 13.3. Market Restraints
• 13.4. Market Opportunities
• 13.5. Market Challenges
• 13.6. Conclusion

14. GLOBAL Non-fungible TOKENS in healthcare MARKET

• 14.1. Key Assumptions and Methodology
• 14.2. Global Non-fungible Tokens in Healthcare Market, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 14.2.1. Multivariate Scenario Analysis
    • 14.2.1.1. Conservative Scenario
    • 14.2.1.2. Optimistic Scenario
• 14.3. Key Market Segmentations

15. Non-fungible TOKENS in healthcare MARKET, BY Blockchain Used

• 15.1. Key Assumptions and Methodology
• 15.2. Non-fungible Tokens in Healthcare Market: Distribution by Blockchain Used
  • 15.2.1. Non-fungible Tokens in Healthcare Market for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 15.2.2. Non-fungible Tokens in Healthcare Market for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 15.2.3. Non-fungible Tokens in Healthcare Market for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 15.2.4. Non-fungible Tokens in Healthcare Market for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 15.3. Data Triangulation and Validation
  • 15.3.1. Secondary Sources
  • 15.3.2. Primary Sources

16. Non-fungible TOKENS in Healthcare MARKET, BY APPLICATION AREA

• 16.1. Key Assumptions and Methodology
• 16.2. Non-fungible Tokens in Healthcare Market: Distribution by Application Area
  • 16.2.1. Non-fungible Tokens in Healthcare Market for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.2. Non-fungible Tokens in Healthcare Market for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.3. Non-fungible Tokens in Healthcare Market for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.4. Non-fungible Tokens in Healthcare Market for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.5. Non-fungible Tokens in Healthcare Market for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.6. Non-fungible Tokens in Healthcare Market for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 16.3. Data Triangulation and Validation
  • 16.3.1. Secondary Sources
  • 16.3.2. Primary Sources

17. Non-fungible TOKENS in healthcare MARKET, BY End-user

• 17.1. Key Assumptions and Methodology
• 17.2. Non-fungible Tokens in Healthcare Market: Distribution by End-user
  • 17.2.1. Non-fungible Tokens in Healthcare Market for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.2. Non-fungible Tokens in Healthcare Market for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.3. Non-fungible Tokens in Healthcare Market for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.4. Non-fungible Tokens in Healthcare Market for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.5. Non-fungible Tokens in Healthcare Market for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.6. Non-fungible Tokens in Healthcare Market for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 17.3. Data Triangulation and Validation
  • 17.3.1. Secondary Sources
  • 17.3.2. Primary Sources

18. Non-fungible TOKENS in healthcare MARKET, BY Geographical Regions

• 18.1. Key Assumptions and Methodology
• 18.2. Non-fungible Tokens in Healthcare Market: Distribution by Geographical Regions
  • 18.2.1. Non-fungible Tokens in Healthcare Market in North America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.1.1. Non-fungible Tokens in Healthcare Market in the US, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.1.2. Non-fungible Tokens in Healthcare Market in Canada, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.2. Non-fungible Tokens in Healthcare Market in Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.1. Non-fungible Tokens in Healthcare Market in Germany, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.2. Non-fungible Tokens in Healthcare Market in the UK, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.3. Non-fungible Tokens in Healthcare Market in Spain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.4. Non-fungible Tokens in Healthcare Market in Rest of the Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.1. Non-fungible Tokens in Healthcare Market in China, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.2. Non-fungible Tokens in Healthcare Market in the South Korea, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.3. Non-fungible Tokens in Healthcare Market in India, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.4. Non-fungible Tokens in Healthcare Market in Rest of the Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.4.1. Non-fungible Tokens in Healthcare Market in Saudi Arabia, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.4.2. Non-fungible Tokens in Healthcare Market in UAE, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.4.3. Non-fungible Tokens in Healthcare Market in Rest of the Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.5. Non-fungible Tokens in Healthcare Market in Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.5.1. Non-fungible Tokens in Healthcare Market in Brazil, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.5.2. Non-fungible Tokens in Healthcare Market in Argentina, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.5.3. Non-fungible Tokens in Healthcare Market in Rest of the Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 18.3 Non-fungible Tokens in Healthcare Market, By Geographical Regions: Market Dynamics Assessment
  • 18.3.1. Penetration-Growth (P-G) Matrix
  • 18.3.2. Market Movement Analysis
• 18.4. Data Triangulation and Validation
  • 18.4.1. Secondary Sources
  • 18.4.2. Primary Sources

SECTION VII: MARKET OPPORTUNITY ANALYSIS WITHIN GEOGRAPHICAL REGIONS**

19. MARKET OPPORTUNITY ANALYSIS: NORTH AMERICA

• 19.1. Non-fungible Tokens in Healthcare Market in North America: Distribution by Blockchain Used
  • 19.1.1. Non-fungible Tokens in Healthcare Market in North America for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.1.2. Non-fungible Tokens in Healthcare Market in North America for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.1.3. Non-fungible Tokens in Healthcare Market in North America for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.1.4. Non-fungible Tokens in Healthcare Market in North America for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 19.2. Non-fungible Tokens in Healthcare Market in North America: Distribution by Application Area
  • 19.2.1. Non-fungible Tokens in Healthcare Market in North America for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.2. Non-fungible Tokens in Healthcare Market in North America for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.3. Non-fungible Tokens in Healthcare Market in North America for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.4. Non-fungible Tokens in Healthcare Market in North America for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.5. Non-fungible Tokens in Healthcare Market in North America for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.6. Non-fungible Tokens in Healthcare Market in North America for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 19.3. Non-fungible Tokens in Healthcare Market in North America: Distribution by End-user
  • 19.3.1. Non-fungible Tokens in Healthcare Market in North America for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.2. Non-fungible Tokens in Healthcare Market in North America for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.3. Non-fungible Tokens in Healthcare Market in North America for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.4. Non-fungible Tokens in Healthcare Market in North America for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.5. Non-fungible Tokens in Healthcare Market in North America for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.6. Non-fungible Tokens in Healthcare Market in North America for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

20. MARKET OPPORTUNITY ANALYSIS: EUROPE

• 20.1. Non-fungible Tokens in Healthcare Market in Europe: Distribution by Blockchain Used
  • 20.1.1. Non-fungible Tokens in Healthcare Market in Europe for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.1.2. Non-fungible Tokens in Healthcare Market in Europe for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.1.3. Non-fungible Tokens in Healthcare Market in Europe for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.1.4. Non-fungible Tokens in Healthcare Market in Europe for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 20.2. Non-fungible Tokens in Healthcare Market in Europe: Distribution by Application Area
  • 20.2.1. Non-fungible Tokens in Healthcare Market in Europe for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.2. Non-fungible Tokens in Healthcare Market in Europe for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.3. Non-fungible Tokens in Healthcare Market in Europe for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.4. Non-fungible Tokens in Healthcare Market in Europe for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.5. Non-fungible Tokens in Healthcare Market in Europe for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.6. Non-fungible Tokens in Healthcare Market in Europe for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 20.3. Non-fungible Tokens in Healthcare Market in Europe: Distribution by End-user
  • 20.3.1. Non-fungible Tokens in Healthcare Market in Europe for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.2. Non-fungible Tokens in Healthcare Market in Europe for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.3. Non-fungible Tokens in Healthcare Market in Europe for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.4. Non-fungible Tokens in Healthcare Market in Europe for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.5. Non-fungible Tokens in Healthcare Market in Europe for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.6. Non-fungible Tokens in Healthcare Market in Europe for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

21. MARKET OPPORTUNITY ANALYSIS: ASIA-PACIFIC

• 21.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Blockchain Used
  • 21.1.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.1.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.1.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.1.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 21.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Application Area
  • 21.2.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.5. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.6. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 21.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by End-user
  • 21.3.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.5. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.6. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

22. MARKET OPPORTUNITY ANALYSIS: MIDDLE EAST AND NORTH AFRICA

• 22.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Blockchain Used
  • 22.1.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.1.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.1.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.1.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 22.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Application Area
  • 22.2.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.5. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.6. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 22.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by End-user
  • 22.3.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.5. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.6. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

23. MARKET OPPORTUNITY ANALYSIS: LATIN AMERICA

• 23.1. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Blockchain Used
  • 23.1.1. Non-fungible Tokens in Healthcare Market in Latin America for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.1.2. Non-fungible Tokens in Healthcare Market in Latin America for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.1.3. Non-fungible Tokens in Healthcare Market in Latin America for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.1.4. Non-fungible Tokens in Healthcare Market in Latin America for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 23.2. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Application Area
  • 23.2.1. Non-fungible Tokens in Healthcare Market in Latin America for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.2. Non-fungible Tokens in Healthcare Market in Latin America for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.3. Non-fungible Tokens in Healthcare Market in Latin America for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.4. Non-fungible Tokens in Healthcare Market in Latin America for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.5. Non-fungible Tokens in Healthcare Market in Latin America for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.6. Non-fungible Tokens in Healthcare Market in Latin America for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 23.3. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by End-user
  • 23.3.1. Non-fungible Tokens in Healthcare Market in Latin America for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.2. Non-fungible Tokens in Healthcare Market in Latin America for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.3. Non-fungible Tokens in Healthcare Market in Latin America for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.4. Non-fungible Tokens in Healthcare Market in Latin America for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.5. Non-fungible Tokens in Healthcare Market in Latin America for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.6. Non-fungible Tokens in Healthcare Market in Latin America for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• *Detailed information on Section VII is available in the Excel Data Packs shared along with the report**

SECTION VIII: STRATEGIC TOOLS

24. PORTER'S FIVE FORCES ANALYSIS

• 24.1. Overview
• 24.2. Significance of Porter's Five Forces Analysis
• 24.3. Methodology
• 24.4. Porter's Five Forces
  • 24.4.1. Threats of New Entrants
  • 24.4.2. Bargaining Power of Buyers
  • 24.4.3. Bargaining Power of NFT Solution Providers
  • 24.4.4. Threats of Substitute Products
  • 24.4.5. Rivalry Among Existing Competitors
• 24.5. Concluding Remarks

SECTION IX: OTHER EXCLUSIVE INSIGHTS

25. CONCLUDING INSIGHTS

26. INSIGHTS FROM PRIMARY RESEARCH

SECTION X: APPENDICES

27. TABULATED DATA

28. LIST OF COMPANIES AND ORGANIZATIONS

관련자료